Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has collaboration with the University of Southern California Michelson Center for Convergent Bioscience. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNYSE:A
CUSIP00846U10
Phone408-345-8886
Debt
Debt-to-Equity Ratio0.39
Current Ratio3.32
Quick Ratio2.88
Price-To-Earnings
Trailing P/E Ratio28.22
Forward P/E Ratio25.00
P/E Growth2.31
Sales & Book Value
Annual Sales$4.47 billion
Price / Sales4.78
Cash Flow$3.0676 per share
Price / Cash21.76
Book Value$15.02 per share
Price / Book4.44
Profitability
EPS (Most Recent Fiscal Year)$2.36
Net Income$684 million
Net Margins5.02%
Return on Equity18.01%
Return on Assets9.80%
Miscellaneous
Employees13,500
Outstanding Shares319,950,000
Market Cap$21.20 billion
Agilent Technologies (NYSE:A) Frequently Asked Questions
What is Agilent Technologies' stock symbol?
Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."
How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?
Agilent Technologies announced a quarterly dividend on Wednesday, May 16th. Shareholders of record on Tuesday, July 3rd will be given a dividend of $0.149 per share on Wednesday, July 25th. This represents a $0.60 annualized dividend and a yield of 0.89%. The ex-dividend date is Monday, July 2nd. View Agilent Technologies' Dividend History.
How were Agilent Technologies' earnings last quarter?
Agilent Technologies Inc (NYSE:A) posted its quarterly earnings results on Tuesday, August, 14th. The medical research company reported $0.67 EPS for the quarter, topping the Zacks' consensus estimate of $0.63 by $0.04. The medical research company had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.20 billion. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The firm's revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter last year, the business posted $0.59 earnings per share. View Agilent Technologies' Earnings History.
When is Agilent Technologies' next earnings date?
What guidance has Agilent Technologies issued on next quarter's earnings?
Agilent Technologies updated its fourth quarter earnings guidance on Tuesday, August, 14th. The company provided earnings per share guidance of $0.72-0.74 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.73. The company issued revenue guidance of $1.24-1.26 billion, compared to the consensus revenue estimate of $1.26 billion.
What price target have analysts set for A?
10 brokerages have issued 1-year price objectives for Agilent Technologies' stock. Their predictions range from $68.00 to $91.00. On average, they expect Agilent Technologies' stock price to reach $74.70 in the next twelve months. This suggests a possible upside of 11.9% from the stock's current price. View Analyst Price Targets for Agilent Technologies.
What is the consensus analysts' recommendation for Agilent Technologies?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.
Who are some of Agilent Technologies' key competitors?
Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), PerkinElmer (PKI), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Harvard Bioscience (HBIO) and Eyepoint Pharmaceuticals (EYPT).
Who are Agilent Technologies' key executives?
Agilent Technologies' management team includes the folowing people:
- Mr. Michael R. McMullen, CEO, Pres & Director (Age 57)
- Mr. Didier Hirsch, Sr. VP & CFO (Age 67)
- Mr. Mark Doak, Sr. VP & Pres of Agilent CrossLab Group (Age 63)
- Mr. Jacob Thaysen, Sr. VP and Pres of Life Sciences & Applied Markets Group (Age 43)
- Mr. Rodney Gonsalves, Chief Accounting Officer, VP & Corp. Controller (Age 52)
Has Agilent Technologies been receiving favorable news coverage?
News headlines about A stock have been trending somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Agilent Technologies earned a media and rumor sentiment score of 0.08 on Accern's scale. They also gave news headlines about the medical research company an impact score of 47.33 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for Agilent Technologies.
Who are Agilent Technologies' major shareholders?
Agilent Technologies' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.27%), FMR LLC (2.74%), OppenheimerFunds Inc. (2.39%), American Century Companies Inc. (1.43%), Cantillon Capital Management LLC (1.18%) and Bank of New York Mellon Corp (1.05%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.
Which institutional investors are selling Agilent Technologies stock?
A stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, BlackRock Inc., Bank of New York Mellon Corp, Voya Investment Management LLC, PNC Financial Services Group Inc., Natixis, Canada Pension Plan Investment Board and Renaissance Technologies LLC. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.
Which institutional investors are buying Agilent Technologies stock?
A stock was acquired by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., American Century Companies Inc., Marshall Wace LLP, Calamos Advisors LLC, Morgan Stanley, Factory Mutual Insurance Co., Sandhill Capital Partners LLC and Los Angeles Capital Management & Equity Research Inc.. View Insider Buying and Selling for Agilent Technologies.
How do I buy shares of Agilent Technologies?
Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Agilent Technologies' stock price today?
One share of A stock can currently be purchased for approximately $66.75.
How big of a company is Agilent Technologies?
Agilent Technologies has a market capitalization of $21.20 billion and generates $4.47 billion in revenue each year. The medical research company earns $684 million in net income (profit) each year or $2.36 on an earnings per share basis. Agilent Technologies employs 13,500 workers across the globe.
How can I contact Agilent Technologies?
Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]
MarketBeat Community Rating for Agilent Technologies (NYSE A)
MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days.
